Search
for
Sort by
Research 331–360 of 349
- The genetic evolution of skin squamous cell carcinoma: tumor suppressor identity matters
- Keratinocyte Cytokine Networks Associated with Human Melanocytic Nevus Development
- A Melanoma Transplanted in Nude Mice Has Both Host‐ and Tumor‐Derived Blood Vessel‐ and Nerve‐Like Structures
- The role of phosphoglycerate dehydrogenase in cell proliferation and tumor progression
- Structure and Mechanical Properties of Human Trichocyte Keratin Intermediate Filament Protein
- Manganese-Doped Calcium Silicate Nanowire Composite Hydrogels for Melanoma Treatment and Wound Healing
- Acute sensitivity of the oral mucosa to oncogenic <i>K‐ras</i>
- The therapeutic, diagnostic, and prognostic values of extracellular vesicles (exosomes) in dermatology: A systematic review
- Imaging to study solid tumour origin and progression: lessons from research and clinical oncology
- Disease Prevention and Alleviation by Human Myoblast Transplantation
- Aged Skin Cells Nurture Stem Cells toward Regeneration
- Comparison between low-dose chemotherapy and surgery for the treatment of extremity-associated solitary bone lesions in children with Langerhans cell histiocytosis in South China: A case-control study
- Misdiagnosis of eosinophilic cystitis: A case report and literature review
- Human Pigmentation: A Review of Molecular Mechanisms, Genetic Architecture, Evolution, Forensic DNA Phenotyping and Health Implications
- Multi-omics analysis unveils the role of cancer-associated fibroblasts in cutaneous squamous cell carcinoma
- Spectrum of Phenotypes Associated with Human MC1R Variations
- Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study
- Reexamining the Role of Diet in Dermatology
- Vitamin A resolves lineage plasticity to orchestrate stem cell lineage choices
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Network pharmacology and molecular docking analysis on potential molecular targets and mechanism of action of BRAF inhibitors for application in wound healing
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- Abstract 1677: Epithelial hyperplasia induced by a selective B-Raf inhibitor, WYE-130600
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis